InvestorsHub Logo
Followers 9
Posts 627
Boards Moderated 0
Alias Born 06/22/2007

Re: Bill B post# 302012

Tuesday, 09/29/2020 12:22:45 PM

Tuesday, September 29, 2020 12:22:45 PM

Post# of 424550
They have a supplier advantage and could do a deal with say Teva for an AG now and probably keep most of the US market money forever with Teva getting a big cut and the other generics staying away... But the supplier advantage will not last forever.

But JT is of course too stupid to do this that is if he is not waiting to take the company private to do the smart thing.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News